Company Filing History:
3 out of 349 
3 out of 3,539 
Years Active: 2013-2018
Title: Edgar Cook: Innovator in GABA Receptor Modulation
Introduction
Edgar Cook is a notable inventor based in Fairfax Station, VA (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate the GABA receptor. With a total of 3 patents, his work focuses on addressing various mental health and neurological issues.
Latest Patents
One of Edgar Cook's latest patents involves androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties. This invention describes compounds of Structures 1, 2, and 3, which serve as allosteric modulators of the GABA receptor chloride ionophore complex. The applications of these compounds aim to alleviate stress, anxiety, mood disorders, seizures, depression, and treatment of drug and alcohol abuse. Additionally, they are designed to improve memory, address premenstrual disorders, and mitigate neural system damage.
Career Highlights
Throughout his career, Edgar Cook has worked with esteemed organizations such as the Research Triangle Institute and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to contribute to significant advancements in medical research and therapeutic development.
Collaborations
Edgar has collaborated with notable colleagues, including Scott P. Runyon and Michael A. Rogawski. These partnerships have further enriched his research and innovation efforts.
Conclusion
Edgar Cook's work in the field of GABA receptor modulation showcases his dedication to improving mental health and neurological treatments. His innovative patents and collaborations highlight his significant impact on pharmacological research.